Physician profile
Stella Chalouh
NPI 1942427273
$2,610.93
in general payments reported to CMS, 2019-2025
18 companies · $176 in 2025
The $176 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $791 · 2022: $721 · 2023: $316 · 2024: $607 · 2025: $176.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,098.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,098.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $655.97 | 2021-2025 | Breztri, Airsupra, Farxiga |
| Abbvie INC. | $442.74 | 2021-2024 | |
| Novo Nordisk INC | $392.55 | 2021-2024 | Rybelsus, Ozempic |
| Intuity Medical INC | $233.60 | 2022-2023 | Pogo Automatic Blood Glucose Monitoring System |
| Lilly USA, LLC | $230.72 | 2021-2025 | Mounjaro, Zepbound |
| Novartis Pharmaceuticals Corporation | $120.28 | 2021-2022 | |
| Corcept Therapeutics | $102.06 | 2024-2025 | Korlym |
| Amgen INC. | $89.07 | 2022-2025 | Otezla, Repatha, Evenity |
| Esperion Therapeutics, INC. | $62.12 | 2021-2024 | Nexletol |
| Almatica Pharma LLC | $60.48 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $46.21 | 2021-2023 | Trulance, Xifaxan |
| Glaxosmithkline, LLC. | $39.97 | 2021-2022 | |
| Amarin Pharma, INC. | $24.17 | 2022 | |
| Avanir Pharmaceuticals, INC. | $23.95 | 2022 | |
| Otsuka America Pharmaceutical, INC. | $23.17 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $22.33 | 2025 | |
| Exact Sciences Corporation | $22.28 | 2023 | Cologuard Collection Kit |
| Takeda Pharmaceuticals U.S.A., INC. | $19.26 | 2024 | Trintellix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stella Chalouh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.